Literature DB >> 23815599

An adenine insertion in exon 6 of human GP6 generates a truncated protein associated with a bleeding disorder in four Chilean families.

V Matus1, G Valenzuela, C G Sáez, P Hidalgo, M Lagos, E Aranda, O Panes, J Pereira, X Pillois, A T Nurden, D Mezzano.   

Abstract

BACKGROUND: Glycoprotein VI (GPVI), 60-65 kDa, is a major collagen receptor on platelet membranes involved in adhesive and signaling responses. Mice lacking GPVI have impaired platelet response to collagen and defective primary adhesion and subsequent thrombus formation. Complete or partial deficiency of GPVI in humans is a rare condition presenting as a mild bleeding disorder. The defect in most of the reported patients is acquired and associated with other diseases. To date, only two patients have been characterized at the molecular level who carry different compound heterozygous mutations in the GP6 gene.
OBJECTIVE: To report four unrelated patients from non-consanguineous families who presented with mucocutaneous bleeding. They had absent platelet aggregation and (14) C-5-HT secretion with collagen, convulxin and collagen-related peptide.
RESULTS: Flow cytometry and immunofluorescence-confocal microscopy showed an absence of GPVI in non-permeabilized platelets. All the patients had an adenine insertion in exon 6 (c.711_712insA), changing the reading frame and generating a premature 'stop codon' in site 242 of the protein. The mutation predicts the synthesis of the truncated protein before the trans-membrane domain, corresponding to a band of ≈49 kDa observed in western blots and in permeabilized platelets by immunofluorescence. Platelet mRNA from all the patients was sequenced and contained the corresponding adenine insertion. Heterozygous relatives had no pathological bleeding, normal response to collagen and convulxin and intermediate membrane expression of GPVI.
CONCLUSIONS: The identification of four unrelated homozygous patients with an identical defect suggests that inherited GPVI deficiency is more frequent than previously suspected, at least in Chile.
© 2013 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  Blood platelet disorders; Glycoprotein VI (platelet), human; Hemorrhagic disorders; Platelet membrane glycoproteins; Platelet receptor for collagen

Mesh:

Substances:

Year:  2013        PMID: 23815599     DOI: 10.1111/jth.12334

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  19 in total

1.  Real-World Use of Fostamatinib in Patients with Immune Thrombocytopenia and Thrombotic Risk.

Authors:  Amit R Mehta; Aron Kefela; Charina Toste; Donald Sweet
Journal:  Acta Haematol       Date:  2021-12-14       Impact factor: 3.068

Review 2.  Functional significance of the platelet immune receptors GPVI and CLEC-2.

Authors:  Julie Rayes; Steve P Watson; Bernhard Nieswandt
Journal:  J Clin Invest       Date:  2019-01-02       Impact factor: 14.808

3.  Glycoprotein VI Blockade: Not Just Targeting Collagen Anymore?

Authors:  Shuchi Gupta; Lawrence F Brass
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-08-26       Impact factor: 8.311

4.  Fibrin and D-dimer bind to monomeric GPVI.

Authors:  Marie-Blanche Onselaer; Alexander T Hardy; Clare Wilson; Ximena Sanchez; Amir K Babar; Jeanette L C Miller; Callum N Watson; Stephanie K Watson; Arkadiusz Bonna; Helen Philippou; Andrew B Herr; Diego Mezzano; Robert A S Ariëns; Steve P Watson
Journal:  Blood Adv       Date:  2017-08-15

5.  Flow studies on human GPVI-deficient blood under coagulating and noncoagulating conditions.

Authors:  Magdolna Nagy; Gina Perrella; Amanda Dalby; M Francisca Becerra; Lourdes Garcia Quintanilla; Jeremy A Pike; Neil V Morgan; Elizabeth E Gardiner; Johan W M Heemskerk; Lorena Azócar; Juan Francisco Miquel; Diego Mezzano; Steve P Watson
Journal:  Blood Adv       Date:  2020-07-14

Review 6.  Inherited Platelet Disorders: An Updated Overview.

Authors:  Verónica Palma-Barqueros; Nuria Revilla; Ana Sánchez; Ana Zamora Cánovas; Agustín Rodriguez-Alén; Ana Marín-Quílez; José Ramón González-Porras; Vicente Vicente; María Luisa Lozano; José María Bastida; José Rivera
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

7.  Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinib.

Authors:  Nichola Cooper; Ivy Altomare; Mark R Thomas; Phillip L R Nicolson; Steve P Watson; Vadim Markovtsov; Leslie K Todd; Esteban Masuda; James B Bussel
Journal:  Ther Adv Hematol       Date:  2021-04-30

8.  GPVI (Glycoprotein VI) Interaction With Fibrinogen Is Mediated by Avidity and the Fibrinogen αC-Region.

Authors:  Rui-Gang Xu; Julia S Gauer; Stephen R Baker; Alexandre Slater; Eleyna M Martin; Helen R McPherson; Cédric Duval; Iain W Manfield; Arkadiusz M Bonna; Steve P Watson; Robert A S Ariëns
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-01-21       Impact factor: 8.311

Review 9.  Inherited platelet disorders: toward DNA-based diagnosis.

Authors:  Claire Lentaigne; Kathleen Freson; Michael A Laffan; Ernest Turro; Willem H Ouwehand
Journal:  Blood       Date:  2016-04-19       Impact factor: 25.476

10.  Fibrin activates GPVI in human and mouse platelets.

Authors:  Osama M Alshehri; Craig E Hughes; Samantha Montague; Stephanie K Watson; Jon Frampton; Markus Bender; Steve P Watson
Journal:  Blood       Date:  2015-08-17       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.